Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vikram Thermo (India)BOM:530477 +2.29%80 Return-on-Tangible-Equity is 21.72% as of Mar. 2026, which is 54% above its 10-year median of 14.06. GuruFocus rates BOM:530477 with a GF Score™ of 80/100 and a GF Value™ of ₹183.23 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 901 Drug Manufacturers companies, Vikram Thermo (India) ranks better than 85.68% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Vikram Thermo (India)'s annualized net income for the quarter that ended in Mar. 2026 was ₹341 Mil. Vikram Thermo (India)'s average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹1,569 Mil. Therefore, Vikram Thermo (India)'s annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 21.72%.
The historical rank and industry rank for Vikram Thermo (India)'s Return-on-Tangible-Equity or its related term are showing as below:
BOM:530477'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 6.17 Med: 14.06 Max: 27.79
Current: 27.79
During the past 13 years, Vikram Thermo (India)'s highest Return-on-Tangible-Equity was 27.79%. The lowest was 6.17%. And the median was 14.06%.
BOM:530477's Return-on-Tangible-Equity is ranked better than 85.68% of 901
companies
in the Drug Manufacturers industry
Industry Median: 7.89
vs BOM:530477: 27.79
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Vikram Thermo (India) Return-on-Tangible-Equity Related Terms
Vikram Thermo (India) Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Vikram Thermo (India)'s Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:530477 vs ZTS: Return-on-Tangible-Equity Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Vikram Thermo (India)'s Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vikram Thermo (India) Return-on-Tangible-Equity vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vikram Thermo (India)'s Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Vikram Thermo (India)'s Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 21.72% mean?
Vikram Thermo (India) (BOM:530477) has a Return-on-Tangible-Equity of 21.72% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Vikram Thermo (India) and its competitors. This is 54% above median its historical median of 14.06. Over the past decade, Vikram Thermo (India)'s Return-on-Tangible-Equity has ranged from 6.17 to 27.79. According to the industry distribution chart, Vikram Thermo (India) ranks #129 out of 901 companies in the Drug Manufacturers industry, placing it in the top 14.3%.
Is Vikram Thermo (India)'s Return-on-Tangible-Equity too high?
Vikram Thermo (India)'s current Return-on-Tangible-Equity of 21.72% is 54% above median its 10-year median of 14.06. Over the past 10 years, this metric has ranged from a low of 6.17 to a high of 27.79. The Drug Manufacturers industry median Return-on-Tangible-Equity is 7.89. Vikram Thermo (India)'s value of 21.72% is 175.3% above this industry median. Based on the distribution chart, Vikram Thermo (India) ranks #129 out of 901 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Vikram Thermo (India) has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vikram Thermo (India)'s Return-on-Tangible-Equity compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Vikram Thermo (India) ranks #129 out of 901 companies for Return-on-Tangible-Equity. This places Vikram Thermo (India) in the top 14% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 7.89. Vikram Thermo (India)'s value of 21.72% is 175.3% above this benchmark. Historically, Vikram Thermo (India)'s own Return-on-Tangible-Equity has ranged from 6.17 to 27.79 over the past decade. While the company's 10-year median is 14.06 vs. the industry median of 7.89, Vikram Thermo (India) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Drug Manufacturers company?
The median Return-on-Tangible-Equity among Drug Manufacturers companies is 7.89, based on 901 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vikram Thermo (India)'s current Return-on-Tangible-Equity of 21.72% is 175.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Vikram Thermo (India) and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Equity is 7.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vikram Thermo (India)'s current Return-on-Tangible-Equity is 21.72%, which is 54% above median its own 10-year median of 14.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vikram Thermo (India) stock overvalued right now?
Based on GuruFocus' analysis, Vikram Thermo (India) (BOM:530477) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹183.23, compared to a current price of ₹250.65 — trading 36.8% above its estimated fair value. The current Return-on-Tangible-Equity is 21.72%, which is 54% above median its 10-year median of 14.06 and 175.3% above the Drug Manufacturers industry median of 7.89. Vikram Thermo (India)'s overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Vikram Thermo (India) (BOM:530477), the current Return-on-Tangible-Equity is 21.72% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vikram Thermo (India) (BOM:530477) Overvalued in 2026?
Based on GuruFocus' analysis, Vikram Thermo (India) stock appears to be overvalued.
The current stock price of ₹250.65 is trading 36.8% above its estimated GF Value™ of ₹183.23.
GuruFocus considers Vikram Thermo (India) to be Significantly Overvalued.
Key valuation signals for BOM:530477:
Return-on-Tangible-Equity: 21.72% (54% above median its 10-year median of 14.06)
GF Value™: ₹183.23 vs. price of ₹250.65 (36.8% above fair value)
Industry Position: 175.3% above the Drug Manufacturers median (#129 of 901)
No single metric tells the full story. See the BOM:530477 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vikram Thermo (India) Ltd is engaged in the manufacturing and selling of basic pharma co-polymer Drug Coat, Diphenyl Oxide, Aquapol line of cosmetic polymers, and Apion line of cross-linked polymers. Through its products, the company provides a complete solution for various applications in the solid oral dosage coating segment with complementary technical support. It operates in a single segment, Chemicals. Geographically, the company generates maximum revenue from its business in India, followed by the Rest of the world.
80GF Score
Get the complete analysis for BOM:530477
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530477 has been successfully added to your 
